Crinetics Pharmaceuticals CRNX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$127.85M-32.1% | -$122.82M-52.4% | -$130.09M-69.3% | -$115.64M-56.2% | -$96.77M-44.6% | ||
| $1.16M+25.4% | $994K+26.1% | $1.01M+31.4% | $959K+27.4% | $925K+95.1% | ||
| $29.68M+44.9% | $21.72M+15.3% | $22.7M+25.1% | $26.12M+37.9% | $20.48M+52.2% | ||
| -$124.7M-41.0% | -$92.9M-38.9% | -$110.72M-76.2% | -$85.85M-80.2% | -$88.45M-67.3% | ||
| $820K-33.8% | $458K-55.5% | $863K+63.4% | $3.2M+235% | $1.24M-7.0% | ||
| -$252.36M-194% | $57.11M+111% | $164.81M— | $37.95M+171% | -$85.96M-27,919% | ||
| $389.88M+8,687% | $26.04M-95.3% | $3.08M-94.6% | $7.06M-6.2% | $4.44M-98.9% | ||
| $12.81M+108% | -$9.76M— | —— | -$40.84M— | -$169.98M-150% | ||
| -$125.52M-40.0% | -$93.36M-37.5% | -$111.58M-76.1% | -$89.05M-83.2% | -$89.69M-65.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Crinetics Pharmaceuticals generate?
- Crinetics Pharmaceuticals (CRNX) generated -$414.2M in operating cash flow over the trailing twelve months.
- What is Crinetics Pharmaceuticals's free cash flow?
- After $5.3M of capital expenditures, Crinetics Pharmaceuticals's free cash flow was -$419.5M over the trailing twelve months, down 55.6% year over year.
- Where does Crinetics Pharmaceuticals's cash flow data come from?
- Every line is extracted from Crinetics Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
